Equity Details
Price & Market Data
Price: $12.46
Daily Change: -$0.68 / 5.46%
Daily Range: $12.19 - $12.90
Market Cap: $10,402,804,736
Daily Volume: 6,228,203
Performance Metrics
1 Week: -6.03%
1 Month: -6.10%
3 Months: -11.25%
6 Months: -7.43%
1 Year: -10.55%
YTD: -11.25%
About Dr. Reddy's Laboratories Limited (RDY)
Get immediate market data for Dr. Reddy's Laboratories Limited (RDY). Price: 12.46, daily change: -$0.68 / 5.46%. Market cap: 10,402,804,736. All performance metrics at your fingertips.
Company Details
Employees: 27811
Sector: Health technology
Industry: Pharmaceuticals: major
Country: India
Details
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.